Displaying drugs 9176 - 9200 of 9970 in total
Talnetant
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.
Investigational
Levopropoxyphene
Levopropoxyphene is a stereoisomer of propoxyphene in the form of 2S, 3R enantiomer. It was sold as an antitussive, but it was removed from the market in the 70s. Levopropoxyphene was developed by Lilly and FDA approved on March 21st, 1962. This drug presented different dosages and it was administered...
Withdrawn
Piromelatine
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Fentiazac
Experimental
Sulfaisodimidine
Sulfaisodimidine also called sulfisomidine is an antibacterial product that has been studied for the treatment of urinary tract infections in the 1950s, however, it is unclear whether this drug has been officially approved for use anywhere .
Experimental
Ibopamine
Experimental
Flumedroxone
Experimental
Mimosine
Mimosine is an antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.
Experimental
3-Chloroalaninate
Experimental
3-sulfino-L-alanine
Experimental
S-(D-Carboxybutyl)-L-Homocysteine
Experimental
Phosphonothreonine
The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem]
Experimental
D-Glutamic Acid
Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.
Experimental
Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine
Experimental
4-phospho-D-erythronic acid
Experimental
N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
Experimental
S-Phosphocysteine
Experimental
D-Threonine
Experimental
2-Dehydropantoate
Experimental
(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine
Experimental
Jaspisamide A
Experimental
Displaying drugs 9176 - 9200 of 9970 in total